Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEMPEDOIC ACID vs BENRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEMPEDOIC ACID vs BENRALIZUMAB: Safety Overview

Metric BEMPEDOIC ACID BENRALIZUMAB
Total FAERS Reports 1,702 15,738
Deaths Reported 6 1,618
Death Rate 0.4% 10.3%
Hospitalizations 121 3,707
Average Patient Age 67.5 yrs 59.1 yrs
% Female Patients 62.7% 69.4%
FDA Approval Date Feb 21, 2020 N/A
Manufacturer Esperion Therapeutics, Inc. AstraZeneca Pharmaceuticals LP
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription